Table 6.
Length of hospital stay following open and laparoscopic surgeries
Trial | Measure | Length of hospital stay, d | p value | |
---|---|---|---|---|
Open surgery | Laparoscopic surgery | |||
Colon cancer | ||||
COLOR14 | mean ± SD | 9.3 ± 7.3 | 8.2 ± 6.6 | < 0.001 |
COST16 | median (IQR) | 6 (5–7) | 5 (4–6) | < 0.001 |
Barcelona22 | mean ± SD | 7.9 ± 9.3 | 5.2 ± 2.1 | 0.005 |
Liang et al.23 | mean ± SD | 14.0 ± 2.0 | 9.0 ± 1.0 | < 0.001 |
LAPKON II26 | mean ± SD median (range) |
13.0 ± 8.6 12 (4–109) |
13.4 ± 12.0 10 (1–123) |
0.032 |
ALCCaS27 | median (range) mean ± SD |
8 (4–59) 10.6 ± 7.2 |
7 (1–55) 9.5 ± 7.4 |
< 0.001 0.07 |
CLASICC21 | median (IQR) | 9 (8–13) | 9 (7–12) | NA |
Rectal cancer | ||||
CLASICC21 | median (IQR) | 11 (9–15) | 13 (9–18) | NA |
COREAN34 | median (IQR) | 9 (8–12) | 8 (7–12) | 0.06 |
Lujan et al.36 | mean ± SD | 9.9 ± 6.8 | 8.2 ± 7.3 | 0.11 |
Ng et al.37 | median (range) | 11.5 (3–38) | 10.8 (5–27) | 0.55 |
Ng et al. 39 | median (range) | 10 (3–39) | 8.4 (2–32) | 0.013 |
Braga et al.41 | mean ± SD | 13.0 ± 10.0 | 10.0 ± 4.9 | 0.004 |
Zhou et al.42 | mean ± SD | 13.3 ± 3.4 | 8.1 ± 3.1 | 0.001 |
ALCCaS = Australasian Laparoscopic Colon Cancer Study; CLASICC = Conventional Versus Laparoscopic-Assisted Surgery in Patients with Colorectal Cancer; COLOR = Colon cancer Laparoscopic or Open Resection; COREAN = Comparison of Open versus laparoscopic surgery for mid and low Rectal cancer After Neoadjuvant chemoradiotherapy; COST = Clinical Outcomes of Surgical Therapy; IQR = interquartile range; NA = not available; SD = standard deviation.